Saudi Arabia says it intercepts missile attack over capital    Bayern underline title credentials with 5-1 rout of Cologne    In pictures: Minister inspects precautionary measures at Cairo, Ain Shams universities on 1st exam day    Egypt will provide property tax services online via Digital Egypt platform    Egypt counts on private sector to increase growth levels: Madbouly    Egypt's FEDCOC aims at attracting European finance for development projects in S.Sinai    Egypt lifts ban on Ramadan's Taraweeh prayers in some mosques amid strict coronavirus measures    Moody's sees Emerging markets' real GDP to grow by 13.9% in 2021, 5% in 2022    Live score: Leeds United v Aston Villa (English Premier League)    Myanmar police crack down on protests after envoy appeals to UN to stop coup    Trump the dominant force at conservative conference    Olympics: Tokyo 2020 committee to pick at least 11 women to join board: Media    Egypt detects 601 new coronavirus cases; 49 deaths on Friday    Sisi urges establishing Shinzo Abe axis east of Cairo based on advanced engineering plan    GameStop shares soar as 'meme stocks' rally again    Egypt briefs Arab, European ambassadors on developments in GERD dispute    Whirling Dervish: Egyptian artist Abdelhamid Tahoun among winners of Sony World Photography Awards    Egypt's Sisi directs government to scale up qualification programs for rural women pioneers    Egyptians can register for COVID-19 vaccine next Sunday    Eschewing the radical    Senate prepares for its first session    Cairo theatres programme: 25 February - 3 March 2021    Egypt's Sarwa Insurance partners with Hannover Re to offer COVID-19 related travel insurance    Tales of the city    King Tutankhamun funerary mask is must-see tourist icon: The Telegraph    Russian flights to return to Sharm el-Sheikh and Hurghada for first time since 2015    Australia slams Facebook's move to block news as unnecessary and heavy-handed    Sisi calls on securing fair access to coronavirus vaccines for African nations    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Egypt reserves doses of anticipated Pfizer and Oxford trial coronavirus vaccines – minister
Published in Amwal Al Ghad on 11 - 11 - 2020

Egypt has reserved doses of a potential coronavirus vaccine developed by Pfizer Inc and BioNTech that would cover up to 20 percent of the country's needs, its health minister said in a statement on Tuesday.
Hala Zayed said the country has also secured doses of a promising British vaccine developed by AstraZeneca and Oxford University that will meet around 30 percent of the country's needs.
On Monday, U.S. pharmaceutical Pfizer and its German partner BioNTech announced their Covid-19 vaccine candidate, BNT162b2 is more than 90 percent effective based on results of initial third-phase a large-scale trial.
Pfizer revealed that up to 1.3 billion doses of the vaccine could be produced in 2021.
"The mRNA-based vaccine candidate demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study," Pfizer said in a statement.
Later in the day, the World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus hailed Pfizer and BioNTech‘s announcement on the efficacy of their coronavirus vaccine as ‘encouraging'.
"We welcome the encouraging vaccine news from Pfizer and BioNTech Group and salute all scientists and partners around the who are developing new safe, efficacious tools to beat COVID19." Ghebreyesus tweeted.
While AstraZeneca-Oxford's vaccine, which has been shown in an early trial to prompt a protective immune response, is expected to be rolled out by the end of the year.
Zayed added that as many as eleven coronavirus vaccines have reached advanced stages, and Egypt is participating in the clinical trials of two of them.
In July, Egypt was selected by China to serve as a future African hub for manufacturing its possible coronavirus vaccines, if Beijing develops one.
Trials of two China-made vaccines are being carried out in Egypt in cooperation with the Chinese government and other drugmakers.


Clic here to read the story from its source.